Related Experiment Video

Updated: Jul 29, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase

H Fujimoto1, N Onishi, N Kato

  • 11Department of Genome Sciences, Faculty of Medical Sciences, Graduate School of Medicine, Kobe University, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.

Cell Death and Differentiation
|November 29, 2005
PubMed

Insights

The protein Wip1 (wild-type p53-inducible phosphatase 1) dephosphorylates and inhibits the DNA damage response kinase Chk2. Wip1 negatively regulates Chk2, impacting cell-cycle checkpoint control.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Chk2 kinase is crucial for DNA damage-induced cell-cycle checkpoints.
  • Wip1 (wild-type p53-inducible phosphatase 1) is an oncogenic protein phosphatase.
  • Wip1 is induced by p53 and regulates cellular responses to DNA damage.

Purpose of the Study:

  • To investigate the interaction and functional relationship between Chk2 kinase and Wip1 phosphatase.
  • To determine if Wip1 affects Chk2 phosphorylation and activity.
  • To elucidate the role of Wip1 in DNA damage response pathways.

Main Methods:

  • Cell culture experiments to assess Chk2 phosphorylation.
  • Expression of wild-type and mutant Wip1.
  • In vitro phosphatase assays using purified proteins.
  • RNA interference to inhibit Wip1 expression.

Main Results:

  • Wild-type Wip1, but not a phosphatase-deficient mutant, inhibited Chk2 phosphorylation at Thr68 in cells.
  • In vitro assays confirmed Wip1 dephosphorylates Chk2 at Thr68, reducing its kinase activity.
  • Wip1 depletion led to sustained Chk2 phosphorylation and increased DNA damage sensitivity.

Conclusions:

  • Wip1 acts as a negative regulator of Chk2 kinase activity.
  • Wip1 dephosphorylation of Chk2 is a key mechanism controlling the DNA damage response.
  • Wip1's interaction with Chk2 has implications for cancer biology and therapeutic strategies.

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...